USP1 and osteosarcoma: It has been shown that ML323 was a more specific USP1 inhibitor than the previously reported inhibitors pimozide and GW7647, and it enhanced cisplatin cytotoxicity in osteosarcoma cells and non-small lung cancer cells (8).